Full Text View
Tabular View
No Study Results Posted
Related Studies
Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression
This study has been completed.
Study NCT00249444   Information provided by New York State Psychiatric Institute

First Received on November 3, 2005.   Last Updated on December 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine Dependence
Depression
Additional conditions recognized in this trial
Cocaine-Related Disorders
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Substance-Related Disorders
Interventions listed in this trial
Mirtazapine
Placebo
Additional drug interventions recognized in this trial
Mianserin
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Central Nervous System Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Sponsors listed in this trial
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services